NeueHealth, Inc. (NEUE)
| Previous close | 6.33 |
| Open | 6.08 |
| Bid | 5.40 x 1000 |
| Ask | 6.97 x 1000 |
| Day's range | 6.06 - 6.48 |
| 52-week range | 4.94 - 37.20 |
| Volume | |
| Avg. volume | 19,552 |
| Market cap | 50.252M |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 24.33 |
Business WireNeueHealth to Host First Quarter 2024 Earnings Conference Call on May 8, 2024
DORAL, Fla., April 18, 2024--NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE), the value-driven healthcare company, today announced it will report First Quarter financial results before the financial markets open on Wednesday, May 8, 2024, followed by a conference call at 8:00 AM Eastern Time.
Business WireNeueHealth Enters into Amendment to its Credit Facility
DORAL, Fla., April 09, 2024--NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE: NEUE), the value-driven healthcare company, today announced that it entered into an incremental amendment to its credit facility with New Enterprise Associates ("NEA") that increases the term loan commitment by $30 million on April 8, 2024. The proceeds of the incremental commitment are intended to be used for general corporate purposes, including to support the Company’s 2024 strategic priorities.
Business WireNeueHealth Reports Fourth Quarter and Full Year 2023 Results
DORAL, Fla., March 06, 2024--NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE: NEUE), the value-driven healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2023.
